Wendy Nembhard
Concepts (346)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Defects, Congenital | 45 | 2024 | 592 | 8.600 |
Why?
| Congenital Abnormalities | 19 | 2024 | 112 | 4.740 |
Why?
| Registries | 28 | 2024 | 518 | 3.500 |
Why?
| Stillbirth | 12 | 2024 | 29 | 3.340 |
Why?
| Infant | 52 | 2024 | 3551 | 2.250 |
Why?
| Gastroschisis | 7 | 2024 | 38 | 2.230 |
Why?
| Pregnancy | 51 | 2024 | 2584 | 2.160 |
Why?
| Infant, Newborn | 47 | 2024 | 2744 | 2.120 |
Why?
| Population Surveillance | 16 | 2023 | 166 | 1.910 |
Why?
| Female | 101 | 2024 | 26329 | 1.750 |
Why?
| Prevalence | 27 | 2024 | 943 | 1.650 |
Why?
| Infant Mortality | 8 | 2024 | 61 | 1.620 |
Why?
| Genetic Predisposition to Disease | 9 | 2024 | 510 | 1.570 |
Why?
| Humans | 125 | 2024 | 49827 | 1.520 |
Why?
| Hypospadias | 5 | 2022 | 33 | 1.490 |
Why?
| Adult | 48 | 2024 | 13160 | 1.320 |
Why?
| Cesarean Section | 3 | 2021 | 187 | 1.320 |
Why?
| Case-Control Studies | 23 | 2024 | 1128 | 1.290 |
Why?
| Child Mortality | 5 | 2020 | 11 | 1.270 |
Why?
| Infant, Small for Gestational Age | 4 | 2020 | 31 | 1.220 |
Why?
| Child | 36 | 2024 | 6824 | 1.170 |
Why?
| Maternal Exposure | 9 | 2024 | 86 | 1.150 |
Why?
| Transposition of Great Vessels | 4 | 2024 | 25 | 1.140 |
Why?
| Retrospective Studies | 31 | 2023 | 6117 | 1.120 |
Why?
| Hernia, Umbilical | 4 | 2024 | 19 | 1.050 |
Why?
| Prenatal Exposure Delayed Effects | 4 | 2021 | 181 | 1.040 |
Why?
| Gestational Age | 8 | 2022 | 417 | 1.020 |
Why?
| Risk Factors | 29 | 2024 | 3619 | 1.000 |
Why?
| United States | 31 | 2024 | 4838 | 0.970 |
Why?
| Lamin Type A | 1 | 2024 | 7 | 0.960 |
Why?
| Male | 57 | 2024 | 25093 | 0.950 |
Why?
| Intellectual Disability | 2 | 2023 | 124 | 0.910 |
Why?
| Pregnancy Outcome | 5 | 2024 | 237 | 0.910 |
Why?
| Young Adult | 23 | 2024 | 3936 | 0.900 |
Why?
| Child, Preschool | 20 | 2022 | 3853 | 0.890 |
Why?
| Policy | 1 | 2023 | 24 | 0.860 |
Why?
| Arkansas | 10 | 2022 | 1967 | 0.860 |
Why?
| Prenatal Diagnosis | 6 | 2021 | 107 | 0.850 |
Why?
| DNA Methylation | 2 | 2024 | 548 | 0.840 |
Why?
| Delivery, Obstetric | 3 | 2020 | 122 | 0.820 |
Why?
| Autistic Disorder | 2 | 2023 | 119 | 0.810 |
Why?
| Insurance, Health | 1 | 2023 | 127 | 0.800 |
Why?
| Insurance Coverage | 1 | 2023 | 102 | 0.800 |
Why?
| Adolescent | 23 | 2024 | 6340 | 0.780 |
Why?
| Genetic Variation | 3 | 2021 | 214 | 0.770 |
Why?
| Placenta | 1 | 2022 | 132 | 0.770 |
Why?
| Health Status Disparities | 3 | 2013 | 195 | 0.770 |
Why?
| Health Services Accessibility | 3 | 2023 | 392 | 0.770 |
Why?
| Live Birth | 11 | 2022 | 23 | 0.760 |
Why?
| Hypoplastic Left Heart Syndrome | 3 | 2023 | 97 | 0.740 |
Why?
| Hospitals, Teaching | 1 | 2020 | 53 | 0.740 |
Why?
| Public Health | 1 | 2023 | 200 | 0.730 |
Why?
| Tobacco, Smokeless | 1 | 2020 | 24 | 0.730 |
Why?
| Cohort Studies | 10 | 2023 | 1422 | 0.720 |
Why?
| Abnormalities, Radiation-Induced | 1 | 2019 | 7 | 0.690 |
Why?
| Hospitals | 1 | 2020 | 175 | 0.670 |
Why?
| Nicotine | 1 | 2020 | 186 | 0.670 |
Why?
| Tobacco Products | 1 | 2020 | 110 | 0.640 |
Why?
| Premature Birth | 3 | 2020 | 147 | 0.590 |
Why?
| Abnormalities, Drug-Induced | 1 | 2017 | 18 | 0.580 |
Why?
| Heart Septal Defects | 1 | 2016 | 11 | 0.560 |
Why?
| Texas | 9 | 2024 | 137 | 0.550 |
Why?
| Air Pollutants | 4 | 2021 | 61 | 0.540 |
Why?
| Maternal Age | 10 | 2024 | 44 | 0.530 |
Why?
| Tetralogy of Fallot | 1 | 2016 | 86 | 0.520 |
Why?
| Developed Countries | 1 | 2015 | 11 | 0.520 |
Why?
| Emergency Treatment | 1 | 2015 | 31 | 0.510 |
Why?
| Hysterectomy | 1 | 2015 | 88 | 0.500 |
Why?
| Postpartum Hemorrhage | 1 | 2015 | 34 | 0.500 |
Why?
| Genome-Wide Association Study | 4 | 2023 | 166 | 0.480 |
Why?
| Odds Ratio | 12 | 2024 | 548 | 0.470 |
Why?
| Kaplan-Meier Estimate | 6 | 2016 | 469 | 0.460 |
Why?
| Thoracic Surgery | 1 | 2013 | 16 | 0.460 |
Why?
| Neoplasms | 2 | 2020 | 1233 | 0.450 |
Why?
| Neural Tube Defects | 2 | 2023 | 32 | 0.450 |
Why?
| Western Australia | 4 | 2023 | 6 | 0.450 |
Why?
| Educational Status | 4 | 2023 | 222 | 0.450 |
Why?
| Proportional Hazards Models | 7 | 2017 | 406 | 0.440 |
Why?
| Birth Weight | 2 | 2010 | 120 | 0.430 |
Why?
| Urinary Tract Infections | 2 | 2023 | 52 | 0.430 |
Why?
| Down Syndrome | 3 | 2024 | 91 | 0.420 |
Why?
| Infant, Premature, Diseases | 2 | 2017 | 94 | 0.420 |
Why?
| Cleft Palate | 2 | 2023 | 75 | 0.400 |
Why?
| Disabled Persons | 2 | 2023 | 77 | 0.390 |
Why?
| Australia | 3 | 2023 | 83 | 0.390 |
Why?
| Polymorphism, Single Nucleotide | 6 | 2022 | 485 | 0.390 |
Why?
| Birth Certificates | 2 | 2021 | 20 | 0.380 |
Why?
| Florida | 5 | 2019 | 58 | 0.380 |
Why?
| Anophthalmos | 2 | 2022 | 5 | 0.380 |
Why?
| Microphthalmos | 2 | 2022 | 7 | 0.380 |
Why?
| Air Pollution | 3 | 2019 | 43 | 0.370 |
Why?
| Turner Syndrome | 2 | 2023 | 15 | 0.360 |
Why?
| Risk Assessment | 7 | 2021 | 1262 | 0.350 |
Why?
| Exome | 3 | 2024 | 46 | 0.350 |
Why?
| Spinal Dysraphism | 2 | 2020 | 37 | 0.340 |
Why?
| Ultrasonography, Prenatal | 3 | 2021 | 188 | 0.340 |
Why?
| Micronesia | 2 | 2019 | 100 | 0.330 |
Why?
| Comorbidity | 4 | 2023 | 618 | 0.310 |
Why?
| Incidence | 3 | 2023 | 1003 | 0.300 |
Why?
| Cardiology | 2 | 2023 | 89 | 0.300 |
Why?
| Middle Aged | 14 | 2021 | 11997 | 0.290 |
Why?
| Disinfection | 2 | 2024 | 13 | 0.290 |
Why?
| Survival Rate | 6 | 2018 | 905 | 0.290 |
Why?
| Contraception | 2 | 2024 | 30 | 0.290 |
Why?
| CpG Islands | 2 | 2024 | 107 | 0.280 |
Why?
| Infant, Low Birth Weight | 2 | 2021 | 62 | 0.270 |
Why?
| Hepatoblastoma | 2 | 2023 | 4 | 0.270 |
Why?
| Genotype | 4 | 2023 | 538 | 0.270 |
Why?
| Parturition | 3 | 2022 | 49 | 0.270 |
Why?
| Neuroblastoma | 2 | 2023 | 52 | 0.270 |
Why?
| Biliary Atresia | 2 | 2023 | 9 | 0.260 |
Why?
| Disinfectants | 2 | 2024 | 12 | 0.250 |
Why?
| Aortic Coarctation | 2 | 2023 | 31 | 0.250 |
Why?
| Drinking Water | 1 | 2024 | 11 | 0.240 |
Why?
| Water Purification | 1 | 2024 | 8 | 0.240 |
Why?
| Alleles | 3 | 2023 | 251 | 0.240 |
Why?
| Water Pollutants, Chemical | 2 | 2024 | 41 | 0.240 |
Why?
| Limb Deformities, Congenital | 1 | 2024 | 11 | 0.240 |
Why?
| Glaucoma | 1 | 2024 | 30 | 0.230 |
Why?
| Esophageal Atresia | 2 | 2021 | 4 | 0.230 |
Why?
| Analysis of Variance | 2 | 2019 | 565 | 0.230 |
Why?
| Household Products | 1 | 2023 | 2 | 0.230 |
Why?
| Wilms Tumor | 1 | 2023 | 18 | 0.230 |
Why?
| Telemedicine | 2 | 2021 | 443 | 0.230 |
Why?
| Socioeconomic Factors | 5 | 2023 | 580 | 0.220 |
Why?
| Pregnancy Complications | 2 | 2019 | 382 | 0.220 |
Why?
| Behavioral Risk Factor Surveillance System | 1 | 2023 | 27 | 0.220 |
Why?
| Mothers | 5 | 2023 | 248 | 0.220 |
Why?
| Medically Uninsured | 1 | 2023 | 47 | 0.220 |
Why?
| Anencephaly | 1 | 2022 | 15 | 0.220 |
Why?
| Cleft Lip | 1 | 2023 | 38 | 0.210 |
Why?
| Fetal Death | 1 | 2022 | 23 | 0.210 |
Why?
| Autopsy | 1 | 2022 | 46 | 0.210 |
Why?
| Common Cold | 1 | 2022 | 6 | 0.210 |
Why?
| Bladder Exstrophy | 1 | 2022 | 5 | 0.210 |
Why?
| Heart Septal Defects, Atrial | 1 | 2022 | 44 | 0.210 |
Why?
| Electronic Health Records | 1 | 2024 | 205 | 0.200 |
Why?
| Liver Neoplasms | 2 | 2023 | 332 | 0.200 |
Why?
| Extreme Heat | 1 | 2021 | 3 | 0.200 |
Why?
| Healthcare Disparities | 4 | 2023 | 258 | 0.200 |
Why?
| Birth Intervals | 1 | 2021 | 1 | 0.200 |
Why?
| Pyloric Stenosis, Hypertrophic | 1 | 2022 | 23 | 0.200 |
Why?
| Hydrocephalus | 1 | 2022 | 42 | 0.200 |
Why?
| Cluster Analysis | 1 | 2022 | 235 | 0.200 |
Why?
| Energy Intake | 2 | 2020 | 170 | 0.200 |
Why?
| Kidney Neoplasms | 1 | 2023 | 178 | 0.200 |
Why?
| Cataract | 2 | 2019 | 45 | 0.200 |
Why?
| Nitrogen Dioxide | 2 | 2019 | 8 | 0.200 |
Why?
| Influenza, Human | 1 | 2022 | 85 | 0.190 |
Why?
| Inheritance Patterns | 1 | 2021 | 22 | 0.190 |
Why?
| Chromosome Disorders | 1 | 2021 | 35 | 0.190 |
Why?
| Term Birth | 1 | 2020 | 16 | 0.190 |
Why?
| Quality of Life | 3 | 2021 | 833 | 0.180 |
Why?
| Schools | 1 | 2021 | 165 | 0.180 |
Why?
| Emotions | 1 | 2021 | 165 | 0.180 |
Why?
| Digestive System Abnormalities | 1 | 2019 | 6 | 0.180 |
Why?
| Ozone | 1 | 2019 | 19 | 0.170 |
Why?
| Truncus Arteriosus | 1 | 2019 | 8 | 0.170 |
Why?
| Health Services | 1 | 2020 | 67 | 0.170 |
Why?
| Radioactive Hazard Release | 1 | 2019 | 14 | 0.170 |
Why?
| Gene Regulatory Networks | 1 | 2020 | 107 | 0.170 |
Why?
| Pregnancy, Multiple | 1 | 2019 | 23 | 0.170 |
Why?
| Diacylglycerol Kinase | 1 | 2019 | 5 | 0.170 |
Why?
| Urinalysis | 1 | 2019 | 34 | 0.170 |
Why?
| Logistic Models | 5 | 2023 | 891 | 0.170 |
Why?
| Fetal Diseases | 1 | 2020 | 62 | 0.170 |
Why?
| Gene-Environment Interaction | 1 | 2019 | 36 | 0.170 |
Why?
| Dietary Fats | 1 | 2020 | 133 | 0.170 |
Why?
| Age Factors | 2 | 2020 | 1090 | 0.170 |
Why?
| Substance Abuse Detection | 1 | 2019 | 92 | 0.170 |
Why?
| Cross-Sectional Studies | 3 | 2022 | 1541 | 0.170 |
Why?
| Chi-Square Distribution | 1 | 2019 | 282 | 0.170 |
Why?
| Abortion, Induced | 1 | 2018 | 19 | 0.160 |
Why?
| Emigrants and Immigrants | 1 | 2019 | 35 | 0.160 |
Why?
| Cannabis | 1 | 2021 | 145 | 0.160 |
Why?
| Occupational Exposure | 1 | 2020 | 122 | 0.160 |
Why?
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 12 | 0.160 |
Why?
| Education, Medical, Graduate | 1 | 2020 | 208 | 0.160 |
Why?
| Cause of Death | 3 | 2017 | 145 | 0.160 |
Why?
| Binge Drinking | 1 | 2018 | 24 | 0.150 |
Why?
| Multivariate Analysis | 1 | 2019 | 585 | 0.150 |
Why?
| Genotyping Techniques | 1 | 2017 | 20 | 0.150 |
Why?
| Genetic Testing | 1 | 2018 | 116 | 0.150 |
Why?
| Smoking Cessation | 1 | 2020 | 299 | 0.140 |
Why?
| Follow-Up Studies | 4 | 2023 | 2179 | 0.140 |
Why?
| Eating | 1 | 2017 | 162 | 0.140 |
Why?
| Gastrointestinal Diseases | 1 | 2017 | 126 | 0.140 |
Why?
| Interviews as Topic | 1 | 2017 | 258 | 0.130 |
Why?
| Particulate Matter | 3 | 2021 | 52 | 0.130 |
Why?
| Peripartum Period | 1 | 2015 | 15 | 0.130 |
Why?
| Gene Expression Profiling | 1 | 2020 | 1031 | 0.130 |
Why?
| Confidence Intervals | 2 | 2016 | 156 | 0.130 |
Why?
| Maternal Mortality | 1 | 2015 | 26 | 0.130 |
Why?
| Diet | 1 | 2019 | 564 | 0.130 |
Why?
| Residence Characteristics | 2 | 2014 | 151 | 0.130 |
Why?
| Hypertension | 2 | 2014 | 532 | 0.120 |
Why?
| Starvation | 1 | 2014 | 12 | 0.120 |
Why?
| Sex Factors | 4 | 2017 | 693 | 0.120 |
Why?
| Public Health Surveillance | 1 | 2013 | 13 | 0.110 |
Why?
| Substance-Related Disorders | 1 | 2019 | 595 | 0.110 |
Why?
| Heart Diseases | 2 | 2014 | 208 | 0.110 |
Why?
| Environmental Exposure | 3 | 2023 | 200 | 0.110 |
Why?
| Survival Analysis | 2 | 2014 | 659 | 0.110 |
Why?
| Trihalomethanes | 2 | 2024 | 2 | 0.110 |
Why?
| Time-to-Treatment | 1 | 2013 | 62 | 0.110 |
Why?
| Research Design | 1 | 2015 | 343 | 0.110 |
Why?
| Poverty | 1 | 2014 | 201 | 0.110 |
Why?
| Pesticides | 1 | 2012 | 18 | 0.110 |
Why?
| Respiratory Sounds | 1 | 2012 | 47 | 0.100 |
Why?
| Acculturation | 1 | 2012 | 21 | 0.100 |
Why?
| Cough | 1 | 2012 | 54 | 0.100 |
Why?
| Referral and Consultation | 1 | 2014 | 287 | 0.100 |
Why?
| Thiazolidinediones | 1 | 2012 | 82 | 0.100 |
Why?
| Chlorophenols | 1 | 2011 | 1 | 0.100 |
Why?
| Fractures, Bone | 1 | 2012 | 106 | 0.100 |
Why?
| Anticonvulsants | 1 | 2012 | 122 | 0.100 |
Why?
| Academic Medical Centers | 1 | 2012 | 132 | 0.100 |
Why?
| Health Services Needs and Demand | 2 | 2024 | 158 | 0.100 |
Why?
| Hypoglycemic Agents | 1 | 2012 | 166 | 0.090 |
Why?
| Infant, Premature | 2 | 2017 | 308 | 0.090 |
Why?
| Infant, Very Low Birth Weight | 1 | 2010 | 45 | 0.090 |
Why?
| Counseling | 2 | 2023 | 133 | 0.090 |
Why?
| Folic Acid | 2 | 2023 | 135 | 0.090 |
Why?
| Epilepsy | 1 | 2012 | 174 | 0.090 |
Why?
| South America | 2 | 2019 | 3 | 0.090 |
Why?
| Patient Acceptance of Health Care | 2 | 2023 | 327 | 0.090 |
Why?
| Asia | 2 | 2019 | 20 | 0.090 |
Why?
| Cognition | 2 | 2023 | 336 | 0.090 |
Why?
| Europe | 2 | 2019 | 74 | 0.090 |
Why?
| North America | 2 | 2019 | 66 | 0.090 |
Why?
| Sex Distribution | 1 | 2009 | 135 | 0.080 |
Why?
| Disease Susceptibility | 1 | 2009 | 89 | 0.080 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2011 | 173 | 0.080 |
Why?
| Health Surveys | 2 | 2024 | 232 | 0.080 |
Why?
| Fetal Growth Retardation | 1 | 2009 | 41 | 0.080 |
Why?
| Nutritional Status | 2 | 2020 | 140 | 0.080 |
Why?
| Fetal Development | 1 | 2009 | 60 | 0.080 |
Why?
| Morbidity | 1 | 2009 | 138 | 0.080 |
Why?
| Georgia | 3 | 2021 | 42 | 0.080 |
Why?
| Abnormalities, Multiple | 2 | 2019 | 167 | 0.070 |
Why?
| Time Factors | 3 | 2019 | 2912 | 0.070 |
Why?
| Heart Failure | 1 | 2012 | 454 | 0.070 |
Why?
| Aged | 4 | 2021 | 9272 | 0.070 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2012 | 467 | 0.070 |
Why?
| Reproducibility of Results | 2 | 2021 | 1188 | 0.070 |
Why?
| Water Supply | 1 | 2024 | 22 | 0.060 |
Why?
| Genetic Diseases, Inborn | 1 | 2024 | 24 | 0.060 |
Why?
| Analgesia, Epidural | 1 | 2004 | 28 | 0.060 |
Why?
| Analgesia, Obstetrical | 1 | 2004 | 26 | 0.060 |
Why?
| Prescription Drugs | 1 | 2024 | 38 | 0.060 |
Why?
| Prejudice | 1 | 2004 | 39 | 0.060 |
Why?
| Neural Crest | 1 | 2023 | 1 | 0.060 |
Why?
| Cerebral Ventricles | 1 | 2023 | 28 | 0.060 |
Why?
| Calpain | 1 | 2023 | 25 | 0.060 |
Why?
| Reproductive Health | 1 | 2023 | 8 | 0.060 |
Why?
| Homozygote | 1 | 2023 | 56 | 0.050 |
Why?
| Workplace | 1 | 2004 | 94 | 0.050 |
Why?
| Models, Genetic | 1 | 2023 | 174 | 0.050 |
Why?
| Poisson Distribution | 1 | 2022 | 34 | 0.050 |
Why?
| Vitamins | 1 | 2022 | 64 | 0.050 |
Why?
| Syndrome | 1 | 2023 | 234 | 0.050 |
Why?
| Aorta | 1 | 2023 | 160 | 0.050 |
Why?
| Seroepidemiologic Studies | 1 | 2022 | 43 | 0.050 |
Why?
| Data Collection | 1 | 2023 | 279 | 0.050 |
Why?
| Stress, Psychological | 1 | 2004 | 260 | 0.050 |
Why?
| Medicaid | 1 | 2004 | 257 | 0.050 |
Why?
| Mutation, Missense | 1 | 2022 | 103 | 0.050 |
Why?
| Fever | 1 | 2022 | 117 | 0.050 |
Why?
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2021 | 5 | 0.050 |
Why?
| Arizona | 1 | 2021 | 12 | 0.050 |
Why?
| Cities | 1 | 2021 | 18 | 0.050 |
Why?
| Membrane Proteins | 1 | 2023 | 342 | 0.050 |
Why?
| Chromosome Mapping | 1 | 2021 | 160 | 0.050 |
Why?
| Delivery of Health Care | 1 | 2023 | 307 | 0.050 |
Why?
| Nutritive Value | 1 | 2020 | 37 | 0.040 |
Why?
| Parents | 1 | 2023 | 312 | 0.040 |
Why?
| Sulfur Dioxide | 1 | 2019 | 3 | 0.040 |
Why?
| Abdominal Wall | 1 | 2019 | 12 | 0.040 |
Why?
| Laboratories, Hospital | 1 | 2019 | 6 | 0.040 |
Why?
| Jamaica | 1 | 2019 | 9 | 0.040 |
Why?
| Amphetamines | 1 | 2019 | 29 | 0.040 |
Why?
| Particle Size | 1 | 2019 | 75 | 0.040 |
Why?
| Bayes Theorem | 1 | 2019 | 108 | 0.040 |
Why?
| Maternal Nutritional Physiological Phenomena | 1 | 2020 | 56 | 0.040 |
Why?
| Chromosome Aberrations | 1 | 2021 | 298 | 0.040 |
Why?
| Needs Assessment | 1 | 2020 | 133 | 0.040 |
Why?
| Benzodiazepines | 1 | 2019 | 70 | 0.040 |
Why?
| Mortality | 1 | 2019 | 99 | 0.040 |
Why?
| Ear | 1 | 2018 | 17 | 0.040 |
Why?
| Dietary Supplements | 1 | 2022 | 441 | 0.040 |
Why?
| Eye Abnormalities | 1 | 2018 | 24 | 0.040 |
Why?
| Temperature | 1 | 2019 | 168 | 0.040 |
Why?
| Hematologic Neoplasms | 1 | 2020 | 99 | 0.040 |
Why?
| Methadone | 1 | 2019 | 172 | 0.040 |
Why?
| Fetus | 1 | 2020 | 217 | 0.040 |
Why?
| Mutation | 1 | 2024 | 1293 | 0.040 |
Why?
| Algorithms | 1 | 2022 | 616 | 0.040 |
Why?
| Cocaine | 1 | 2019 | 169 | 0.040 |
Why?
| Family | 1 | 2019 | 169 | 0.040 |
Why?
| Phenotype | 1 | 2021 | 727 | 0.040 |
Why?
| Intestinal Atresia | 1 | 2017 | 5 | 0.040 |
Why?
| Tracheoesophageal Fistula | 1 | 2017 | 9 | 0.040 |
Why?
| Anti-Bacterial Agents | 1 | 2023 | 743 | 0.040 |
Why?
| Vitamin B 6 | 1 | 2017 | 11 | 0.040 |
Why?
| Diet Records | 1 | 2017 | 17 | 0.040 |
Why?
| Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 9 | 0.040 |
Why?
| Lung Diseases | 1 | 2018 | 93 | 0.040 |
Why?
| Pandemics | 1 | 2022 | 554 | 0.040 |
Why?
| Buprenorphine | 1 | 2019 | 134 | 0.040 |
Why?
| Food Analysis | 1 | 2017 | 32 | 0.040 |
Why?
| Vitamin B 12 | 1 | 2017 | 27 | 0.040 |
Why?
| Smoking | 1 | 2021 | 510 | 0.040 |
Why?
| Choline | 1 | 2017 | 61 | 0.040 |
Why?
| Colon | 1 | 2017 | 98 | 0.040 |
Why?
| Epigenesis, Genetic | 1 | 2020 | 373 | 0.040 |
Why?
| Hypertension, Pulmonary | 1 | 2018 | 114 | 0.040 |
Why?
| Gastrointestinal Tract | 1 | 2017 | 103 | 0.040 |
Why?
| Quebec | 1 | 2016 | 13 | 0.040 |
Why?
| Methionine | 1 | 2017 | 135 | 0.030 |
Why?
| Decision Making | 1 | 2018 | 262 | 0.030 |
Why?
| Body Mass Index | 1 | 2019 | 652 | 0.030 |
Why?
| Monte Carlo Method | 1 | 2016 | 84 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2020 | 979 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2017 | 854 | 0.030 |
Why?
| Lung | 1 | 2018 | 480 | 0.030 |
Why?
| Neonatal Screening | 1 | 2015 | 45 | 0.030 |
Why?
| Databases, Factual | 1 | 2017 | 664 | 0.030 |
Why?
| Analgesics, Opioid | 1 | 2019 | 532 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2017 | 942 | 0.030 |
Why?
| China | 1 | 2014 | 87 | 0.030 |
Why?
| Oximetry | 1 | 2014 | 66 | 0.030 |
Why?
| Cardiac Surgical Procedures | 1 | 2016 | 298 | 0.030 |
Why?
| Nutrition Surveys | 1 | 2012 | 104 | 0.030 |
Why?
| Biomedical Research | 1 | 2015 | 231 | 0.030 |
Why?
| Critical Illness | 1 | 2014 | 286 | 0.030 |
Why?
| Body Burden | 1 | 2011 | 11 | 0.020 |
Why?
| Epidemiological Monitoring | 1 | 2011 | 10 | 0.020 |
Why?
| Epidemiologic Methods | 1 | 2011 | 49 | 0.020 |
Why?
| Environmental Monitoring | 1 | 2011 | 65 | 0.020 |
Why?
| Prognosis | 1 | 2015 | 1952 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2016 | 3125 | 0.020 |
Why?
| Animals | 1 | 2023 | 13150 | 0.020 |
Why?
| Heart Ventricles | 1 | 2010 | 248 | 0.020 |
Why?
| Treatment Outcome | 1 | 2016 | 5138 | 0.020 |
Why?
| Labor, Obstetric | 1 | 2004 | 45 | 0.010 |
Why?
| Urban Health | 1 | 2004 | 31 | 0.010 |
Why?
|
|
Nembhard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|